Skip to content

Quantum Exponential - Employee Benefit Trust Share Purchase


Announcement provided by

Quantum Exponential Group plc · QBIT

23/03/2023 07:00

Quantum Exponential - Employee Benefit Trust Share Purchase
RNS Number : 9271T
Quantum Exponential Group PLC
22 March 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.


22 March 2023

 

Quantum Exponential Group plc

 (the 'Company' or 'Quantum Exponential')

 

Employee Benefit Trust Share Purchase

 

 

Quantum Exponential Group plc (AQUIS:QBIT), a company focused on investing in quantum technology announces  that its Employee Benefit Trust (the "EBT"), set up on the 7th June 2022, for the benefit of current and future employees has purchase 2,500,000 Ordinary Shares at 1.65p each ("Ordinary Shares").

 

Following this purchase, the EBT has a total of 16,900,000 Ordinary Shares in Quantum Exponential Group plc representing approximately 5.14 per cent. of the Company's issue share capital.

 

The Directors take responsibility for this announcement.

 

 

**ENDS**

 

For more information, visit the Company's website: www.quantum-exponential.co.uk or contact:

 

Steven Metcalfe, Chief Executive Officer            c/o  quantum@stbridespartners.co.uk

Novum Securities  (AQSE Corporate Adviser)     Tel: +44 (0)20 7399 9400

David Coffman, George Duxberry                           

Oberon Capital (Broker)                                               Tel: +44 (0)20 3179 5344

Mike Seabrook, Chris Crawford

St Brides Partners Limited (Financial PR)              quantum@stbridespartners.co.uk

Catherine Leftley, Ana Ribeiro, Isabelle Morris   

Notes to Editors

About Quantum Exponential Group plc

Quantum Exponential is a first of its kind, AQSE Growth Market SPAC, focused on opportunities in quantum technology and the wider quantum computing sector, with an advisory board made up of industry advisors, entrepreneurs, and technology investment professionals with broad access to quantum opportunities and markets. Quantum Exponential's investment strategy is to assemble a portfolio of minority investments in early-stage global quantum technology companies, primarily in NATO allied countries, offering institutional and private investors access to revolutionising technologies and industries in the realms of artificial intelligence, manufacturing and healthcare.

 

Quantum Exponential trades on AQSE Growth Market under the ticker symbol "QBIT'.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXFZGZFRZNGFZM ]]>

View more ...

QBIT announcementsAll announcements

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2024. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal